National Press Releases

March 20, 2024

Cancer Advocates Celebrate Anniversary of the Affordable Care Act

As one of the leading patient advocacy groups that advocated for the passage of the Affordable Care Act (ACA), the American Cancer Society Cancer Action Network (ACS CAN) is celebrating the impact of the historic law ahead of its 14th anniversary on Saturday. ACS CAN is marking the milestone by urging Congress, state lawmakers and the U.S. Court of Appeals for the Fifth Circuit to protect and strengthen the critical patient protections of the ACA.

March 7, 2024

State of the Union: An Opportunity to Elevate the Nation’s Commitment to the Cancer Moonshot

WASHINGTON, D.C.— March 7, 2024 —Ahead of  President Biden’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the president to emphasize the need for continued bipartisan support for increased federal investment for cancer research at the National Institutes of Health (NIH) and National Cancer Institute (NCI) as well as prevention program funding at the Centers for Disease Control and Prevention (CDC). Additionally, ACS CAN is urging the president to finalize the Food and Drug Administration’s rule prohibiting the sale of menthol in cigarettes without delay. 

March 5, 2024

Philip R. O’Brien Named American Cancer Society Cancer Action Network Cancer Votes National Ambassador

Milwaukee attorney Philip R. O’Brien has accepted the role of Cancer Votes National Ambassador for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society (ACS). This role is an expansion of O’Brien’s current commitment to ACS CAN as a member of its national Board of Directors since 2019. Cancer Votes is ACS CAN’s nonpartisan electoral program, a public education avenue through which cancer issues are elevated as a key priority during election cycles. As National Ambassador, Phil O’Brien will serve as a brand leader, seeking to draw high levels of engagement from volunteers, the media and the advocacy and business communities.

March 4, 2024

Fifth Circuit to Hear Oral Arguments in Case of Braidwood Management v. Becerra

Today, the U.S. Court of Appeals for the Fifth Circuit will hear oral arguments in Braidwood Management v. Becerra, a case that threatens access to evidence-based preventive services without cost-sharing as required under the Affordable Care Act (ACA). The services at-risk include those recommended by scientific experts at the U.S. Preventive Services Task Force (USPSTF), the Advisory Committee on Immunization Practices (ACIP) and the Health Resources and Services Administration (HRSA). 

February 22, 2024

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations.